ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2272

Age and Race-Based Differences in Emergency Department Utilization for Systemic Lupus Erythematosus in the United States

Rashmi Dhital1, Ioannis Karageorgiou2, Ashbina Pokharel3 and Kenneth Kalunian4, 1UC San Diego, San Diego, CA, 2William Beaumont University Hospital, Troy, MI, 3William Beaumont University Hospital, Royal Oak, MI, 4University of California San Diego, La Jolla, CA

Meeting: ACR Convergence 2023

Keywords: Administrative Data, Demographics, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with systemic lupus erythematosus (SLE) frequently visit the emergency department (ED) due to the complex disease course. Previous research highlights infection and pain as key reasons for ED use in SLE. Our previous study using the US National Emergency Department Sample (NEDS) found that SLE ED visits consisted of more young patients, of Black race, with publicly funded insurance and a higher comorbidity burden, but Black patients were less likely to be admitted from the ED. This study aims to further investigate age and race-based variations in ED utilization.

Methods: Using NEDS (2019) discharge data for 989 hospitals, which approximates a 20% sample of US hospital-owned EDs, SLE visits were identified using ICD-10 codes (M32.xx) and categorized by age (18-30, 31-50, 51-64, and ≥ 65 years) and race (White, Black, Hispanic, Others). Demographic features, clinical comorbidities, and the top ten primary diagnoses associated with ED visits were compared across groups.

Results: We identified 414,139 ED SLE visits, 41% of which were visits by adults aged 31-50 years. Young SLE adults (18-30 years) visiting the ED were predominantly Black (47.10%), and had Medicaid (41.70%), while older adults (≥ 65 years) were mostly White (64.70%). Older adults had higher rates of chronic kidney disease (CKD), hyperlipidemia (HLD), hypertension (HTN), diabetes, and cardiovascular diseases (CVDs), but young SLE adults (18-30 years) also exhibited significant comorbidity burdens (CKD: 20.78%, HTN: 33.02%). Analyzing by race, more ED visits by Black and Hispanic SLE patients were in the 18-30 age group (~20%) compared to White patients (< 10%). Medicaid use was notably higher among non-White (27-32%) versus 19% in White patients. Comorbidity patterns varied, with White patients having higher HLD, ischemic heart disease (IHD), and mood disorders while Black patients had higher CKD and HTN (25% vs 13% and 61% vs 48%, respectively). The most common primary diagnosis for ED visits in young SLE adults (18-31 years) was “SLE/Connective tissue disease (CTD)”, whereas sepsis was the most common diagnosis for older adults (≥ 65 years). Heart failure and arrhythmias were among the top 10 diagnoses for adults ≥ 65 years, but not in younger groups. The primary ED diagnosis of SLE/CTD was more common in Black (8.61%) and Hispanic (6.70%) than in White patients (2.99%), with no other major differences in other reasons for ED visits based on race.

Conclusion: In a previous study of general population ED visits, Black patients were less likely to be admitted from the ED, and our study suggested a similar pattern among SLE ED visits. Discriminating determinants appear to be younger age, higher Medicaid use, CKD, HTN, and heart failure amongst Black SLE patients, and higher prevalence of older age groups, and baseline CVDs among White patients. While it appears that increased age and/or more severe CVDs in the White patients may explain the disparate admission rates, further study is needed to confirm whether these discriminating factors are replicated in other datasets and whether other factors such as ED reliance as a primary source of care and insurance coverage affect the lower admission rate amongst Blacks.

Supporting image 1

Table 1. Baseline demographic characteristics and clinical comorbidities of ED encounters in SLE by age categories: National Emergency Department Sample (NEDS), 2019: National Emergency Department Sample (NEDS), 2019

Supporting image 2

Table 2. Baseline demographic characteristics and clinical comorbidities of ED encounters in SLE by racial/ethnic categories: National Emergency Department Sample (NEDS), 2019

Supporting image 3

Figure 1. Top ten primary diagnoses associated with ED visits in SLE by age and race categories, National Emergency Department Sample (NEDS), 2019


Disclosures: R. Dhital: None; I. Karageorgiou: None; A. Pokharel: None; K. Kalunian: AbbVie/Abbott, 2, Amgen, 5, AstraZeneca, 2, Aurinia, 2, Bristol-Myers Squibb(BMS), 2, Eli Lilly, 2, EquilliumBio, 2, Genentech, 2, Gilead, 2, Janssen, 2, KezarBio, 1, Merck/MSD, 2, Novartis, 2, Pfizer, 2, Remegene, 2, Roche, 2, UCB, 5.

To cite this abstract in AMA style:

Dhital R, Karageorgiou I, Pokharel A, Kalunian K. Age and Race-Based Differences in Emergency Department Utilization for Systemic Lupus Erythematosus in the United States [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/age-and-race-based-differences-in-emergency-department-utilization-for-systemic-lupus-erythematosus-in-the-united-states/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/age-and-race-based-differences-in-emergency-department-utilization-for-systemic-lupus-erythematosus-in-the-united-states/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology